---
figid: PMC5849167__oncotarget-09-12705-g005
figlink: /pmc/articles/PMC5849167/figure/F5/
number: Figure 5
caption: Ang-2 has been implicated in mediating inflammatory processes, and upregulated
  in multiple inflammation-related tumors or signaling pathway. With lung cancer volume
  increasing, intratumoral hypoxia in the absence of vascularization resulted in tumor
  cells to express Ang-2 inducing angiogenesis for tumor growth and increasing vascular
  permeability. Overexpression of Ang-2 facilitating proliferation, invasion, metastasis,
  and EMT of lung cancer cells that could be a new mechanism insight into tumor metastasis
  by inhibiting E-cadherin and upregulating VIM, Twist and Snail signaling. Ang, angiopoietin;
  Ang-2, angiopoietin-2; CaMK, calcium/calmodulin-dependent protein kinase; EMT, epithelial-mesenchymal
  transition; ENO1, enolase 1; EPO, erythropoietin; ET1, endothelin-1; GAPDH, glyceraldehyde-3-phosphate
  dehydrogenase; Glut1, glucose transporter 1; HIF-1α, hypoxia-inducible factor-1α;
  HK1, hexokinase 1; HRE, hypoxia-response element; IGF2, insulin-like growth factor
  2; IP3, inositol 1,4,5-trisphate; mTOR, mechanistic target of rapamycin kinase;
  NOS2, nitric oxide synthase 2; Oncogenes, ras, c-myc etc; PLC-γ, phospholipase C
  gamma; PI3K, phosphatidylinositol 3-kinase; PKC, protein kinase C; RTK, receptor
  tyrosine kinase; TGFA, transforming growth factor alpha; tumor suppressor genes,
  pVHL, P53, PTEN, etc. VEGF, vascular endothelial growth factors; VHL, von Hippel-Lidau;
  VIM, Vimentin.
pmcid: PMC5849167
papertitle: Ang-2 promotes lung cancer metastasis by increasing epithelial-mesenchymal
  transition.
reftext: Zhizhen Dong, et al. Oncotarget. 2018 Feb 27;9(16):12705-12717.
pmc_ranked_result_index: '78973'
pathway_score: 0.9668442
filename: oncotarget-09-12705-g005.jpg
figtitle: Ang-2 up-regulating EMT and facilitating lung cancer metastasis
year: '2018'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5849167__oncotarget-09-12705-g005.html
  '@type': Dataset
  description: Ang-2 has been implicated in mediating inflammatory processes, and
    upregulated in multiple inflammation-related tumors or signaling pathway. With
    lung cancer volume increasing, intratumoral hypoxia in the absence of vascularization
    resulted in tumor cells to express Ang-2 inducing angiogenesis for tumor growth
    and increasing vascular permeability. Overexpression of Ang-2 facilitating proliferation,
    invasion, metastasis, and EMT of lung cancer cells that could be a new mechanism
    insight into tumor metastasis by inhibiting E-cadherin and upregulating VIM, Twist
    and Snail signaling. Ang, angiopoietin; Ang-2, angiopoietin-2; CaMK, calcium/calmodulin-dependent
    protein kinase; EMT, epithelial-mesenchymal transition; ENO1, enolase 1; EPO,
    erythropoietin; ET1, endothelin-1; GAPDH, glyceraldehyde-3-phosphate dehydrogenase;
    Glut1, glucose transporter 1; HIF-1α, hypoxia-inducible factor-1α; HK1, hexokinase
    1; HRE, hypoxia-response element; IGF2, insulin-like growth factor 2; IP3, inositol
    1,4,5-trisphate; mTOR, mechanistic target of rapamycin kinase; NOS2, nitric oxide
    synthase 2; Oncogenes, ras, c-myc etc; PLC-γ, phospholipase C gamma; PI3K, phosphatidylinositol
    3-kinase; PKC, protein kinase C; RTK, receptor tyrosine kinase; TGFA, transforming
    growth factor alpha; tumor suppressor genes, pVHL, P53, PTEN, etc. VEGF, vascular
    endothelial growth factors; VHL, von Hippel-Lidau; VIM, Vimentin.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - VEGFD
  - PRKCD
  - PRKCE
  - GPI
  - VEGFB
  - VEGFC
  - VHL
  - VEGFA
  - PRKCH
  - ENO1
  - GAPDH
  - PRKCG
  - PIK3R3
  - PIK3R6
  - PRKD3
  - PIK3CG
  - CAMK1G
  - CAMK2A
  - PRKCI
  - PRKCB
  - CAMK4
  - CDH1
  - PIK3CB
  - PIK3CD
  - PGF
  - VIM
  - AKT2
  - AKT3
  - AKT1
  - OPN1LW
  - EP300
  - CAMK2B
  - CAMK2D
  - PRKCQ
  - CAMK1
  - CAMK1D
  - PRKCA
  - TGFA
  - EPO
  - IGF2
  - MTOR
  - NOS2
  - CAMK2G
  - PIK3R4
  - PIK3CA
  - TP53
  - PIK3R5
  - VCAN
  - ADM
  - PRKCZ
  - PGK1
  - NADPH
  - ENO1
  - Ca
  - Lung cancer
  - VHL
  - hypoxic
genes:
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: GLUTI,GPI,HKI,
  symbol: GPI
  source: hgnc_symbol
  hgnc_symbol: GPI
  entrez: '2821'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: (VHL,
  symbol: VHL
  source: hgnc_symbol
  hgnc_symbol: VHL
  entrez: '7428'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: ENO1,
  symbol: ENO1
  source: hgnc_symbol
  hgnc_symbol: ENO1
  entrez: '2023'
- word: GAPDH,
  symbol: GAPDH
  source: hgnc_symbol
  hgnc_symbol: GAPDH
  entrez: '2597'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: CAMK
  symbol: CAMK
  source: bioentities_symbol
  hgnc_symbol: CAMK1G
  entrez: '57172'
- word: CAMK
  symbol: CAMK
  source: bioentities_symbol
  hgnc_symbol: CAMK2A
  entrez: '815'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: CAMK
  symbol: CAMK
  source: bioentities_symbol
  hgnc_symbol: CAMK4
  entrez: '814'
- word: E-cadherin!)
  symbol: CDH1
  source: hgnc_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: ADM,EPO,ETI,(VIM/SnailTwistt,
  symbol: VIM
  source: hgnc_symbol
  hgnc_symbol: VIM
  entrez: '7431'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: P300/CBP
  symbol: CBP
  source: hgnc_prev_symbol
  hgnc_symbol: OPN1LW
  entrez: '5956'
- word: P300/CBP
  symbol: p300
  source: hgnc_alias_symbol
  hgnc_symbol: EP300
  entrez: '2033'
- word: CAMK
  symbol: CAMK
  source: bioentities_symbol
  hgnc_symbol: CAMK2B
  entrez: '816'
- word: CAMK
  symbol: CAMK
  source: bioentities_symbol
  hgnc_symbol: CAMK2D
  entrez: '817'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: CAMK
  symbol: CAMK
  source: bioentities_symbol
  hgnc_symbol: CAMK1
  entrez: '8536'
- word: CAMK
  symbol: CAMK
  source: bioentities_symbol
  hgnc_symbol: CAMK1D
  entrez: '57118'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: TGFA,
  symbol: TGFA
  source: hgnc_symbol
  hgnc_symbol: TGFA
  entrez: '7039'
- word: ADM,EPO,ETI,(VIM/SnailTwistt,
  symbol: EPO
  source: hgnc_symbol
  hgnc_symbol: EPO
  entrez: '2056'
- word: IGF2,
  symbol: IGF2
  source: hgnc_symbol
  hgnc_symbol: IGF2
  entrez: '3481'
- word: mTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: NOS2,
  symbol: NOS2
  source: hgnc_symbol
  hgnc_symbol: NOS2
  entrez: '4843'
- word: CAMK
  symbol: CAMK
  source: bioentities_symbol
  hgnc_symbol: CAMK2G
  entrez: '818'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: p53,
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PGM,PGK1,ete
  symbol: PG-M
  source: hgnc_alias_symbol
  hgnc_symbol: VCAN
  entrez: '1462'
- word: ADM,EPO,ETI,(VIM/SnailTwistt,
  symbol: ADM
  source: hgnc_symbol
  hgnc_symbol: ADM
  entrez: '133'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PGM,PGK1,ete
  symbol: PGK1
  source: hgnc_symbol
  hgnc_symbol: PGK1
  entrez: '5230'
chemicals:
- word: NADPH
  source: MESH
  identifier: D009249
- word: ENO1
  source: MESH
  identifier: C095157
- word: Ca
  source: MESH
  identifier: D002118
diseases:
- word: Lung cancer
  source: MESH
  identifier: D008175
- word: VHL
  source: MESH
  identifier: D006623
- word: hypoxic
  source: MESH
  identifier: D000860
---
